MXCT
MaxCyte, Inc. · Healthcare
EVP, Global Sales Thomas M. Ross sold $134K of MaxCyte, Inc.
Sold$134,366
$4.03Price
33,333Shares
−57%Stake
What MXCT did after the filing
- The stock from Wed, Jul 10 close, $4.11
- +3.4%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Aug 21 close.
Traded Mon, Jul 8. Filed Wed, Jul 10, 12:15 PM ET, during the session. Returns use the Jul 10 close and the Aug 21 close. Not investment advice.